Screener
Ocular Therapeutix OCUL EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Interest expense | (2,777) | (2,984) |
| Change in fair value of derivative liabilities | 1,455 | (978) |
| Total other income (expense), net | 4,728 | (136) |
| Net loss | $(88,612) | $(64,053) |
| Net loss per share, basic | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, basic | 224,099,410 | 169,396,989 |
| Net loss per share, diluted | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, diluted | 224,099,410 | 169,396,989 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's EPS (basic)?
- Ocular Therapeutix (OCUL) reported EPS (basic) of -$0.40 in Q1 2026.
- How has Ocular Therapeutix's EPS (basic) changed year-over-year?
- Ocular Therapeutix's EPS (basic) decreased by 5.3% year-over-year, from -$0.38 to -$0.40.
- What is the long-term trend for Ocular Therapeutix's EPS (basic)?
- Over 4 years (2021 to 2025), Ocular Therapeutix's EPS (basic) has grown at a 99.3% compound annual growth rate (CAGR), from -$0.09 to -$1.42.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Ocular Therapeutix's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude